Market revenue in 2020 | USD 998.6 million |
Market revenue in 2028 | USD 1,048.5 million |
Growth rate | 0.6% (CAGR from 2020 to 2028) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2016 - 2019 |
Base year | 2020 |
Forecast period | 2021 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | Instruments, Consumables, Services |
Key market players worldwide | Abbott Laboratories, Thermo Fisher Scientific Inc, Koninklijke Philips NV, BD, BioMerieux SA, Bio-Rad Laboratories Inc, QuidelOrtho Corp, Siemens Healthineers AG ADR, Danaher Corp, Qiagen NV, Roche |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious respiratory disease diagnostics market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.47% in 2024. Horizon Databook has segmented the Russia infectious respiratory disease diagnostics market based on instruments, consumables, services covering the revenue growth of each sub-segment from 2018 to 2030.
The infectious respiratory disease diagnostics market in Russia is likely to witness significant growth during the forecast period. This growth is driven by technological advancements and rising consumer awareness.
Favorable government initiatives are likely to have a positive impact on early and accurate diagnosis of respiratory diseases, including pneumonia and COVID-19. Russian Direct Investment Fund (RDIF) introduced a project for the diagnosis of pneumonia and lung complications caused by SARS-CoV-2 virus by utilizing AI-enabled CT scans developed by G42 and Med scan Group in April 2020.
The availability of testing products, coupled with favorable healthcare infrastructure, is expected to propel market growth. As of September 2021, total tests for the diagnosis of COVID-19 was around 184.32 million.
Horizon Databook provides a detailed overview of country-level data and insights on the Russia infectious respiratory disease diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Russia infectious respiratory disease diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account